<DOC>
	<DOCNO>NCT02105623</DOCNO>
	<brief_summary>The purpose study compare standard therapy ( risk factor control , life style modification ) versus standard therapy plus low-dose rosuvastatin therapy ( 5mg/day ) progression coronary atherosclerosis statin naive individual mild CAD ( nonobstructive coronary atherosclerotic plaque ) normal LDL ( low-density lipoprotein ) cholesterol level ( 〈130mg/dl ) .</brief_summary>
	<brief_title>EARly Prevention aTHeroma Progression</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Men woman least 35 year age Mild CAD ( nonobstructive coronary atherosclerotic plaque , lumen narrow &lt; 50 % ) CAC score &lt; 300 least one segment proximal midportion major epicardial coronary artery LDL cholesterol &lt; 130mg/dl History stable angina , acute coronary syndrome History transient ischemic attack , stroke Chronic kidney disease ( eGFR &lt; 60ml/min ) Diabetes mellitus microvascular complication insulin therapy Hypertriglyceridemia ( triglyceride &gt; 500mg/dl ) Any statin therapy past 4 week Planned cardiac surgery plan major noncardiac surgery within 6 month . Chronic disease require treatment oral , intravenous , intraarticular corticosteroid ( use topical , inhaled , nasal corticosteroid permissible ) . A diagnosis cancer ( superficial squamous basal cell skin cancer ) past 3 year current treatment active cancer . Any clinically significant abnormality identify screen visit , physical examination , laboratory test , electrocardiogram , judgment Investigator , would preclude safe completion study . Hepatic disease biliary tract obstruction , significant hepatic enzyme elevation ( ALT AST &gt; 3 time upper limit normal ) . History adult asthma manifest bronchospasm past 6 month , currently take regular antiasthmatic medication ( ) . Unwillingness inability comply procedure describe protocol . Positive pregnancy test ( female subject childbearing potential must urine ßhuman chorionic gonadotropin ( hCG ) pregnancy test perform Screening and/ within 7 day prior randomization ) know pregnant lactating . Hypersensitivity Crestor Skeletal muscle disease Combination use cyclosporine Galactose intolerance , Lapp lactose deficiency glucosegalactose malabsorption Combination use protease inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Coronary Arteriosclerosis</keyword>
	<keyword>rosuvastatin</keyword>
</DOC>